Author

Johan Douglas

Institutions: Blekingesjukhuset, Region Blekinge

Observed institutions: Blekingesjukhuset, Region Blekinge

ORCID: 0000-0003-1018-9719

Observed ORCID: 0000-0003-1018-9719

OpenAlex ID: A5012391587

Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19

2021 · Anders Kjellberg, Johan Douglas, et al. · BMJ Open · 18

Use of Hyperbaric Oxygen in Patients with Necrotizing Soft Tissue Infections: A Scandinavian Multicenter, Prospective, Observational Cohort

2025 · Ole Hyldegaard, Michael Nekludov, et al. · Infectious Diseases and Therapy · 6

COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)

2023 · Anders Kjellberg, Johan Douglas, et al. · Journal of Clinical Medicine · 6

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

2024 · Anders Kjellberg, Johan Douglas, et al. · Respiratory Medicine · 5

[How we work with hyperbaric oxygen therapy].

2011 · Folke Lind, Bengt Eriksson, et al. · PubMed · 2

Works count: 5

Citation count: 37

H-index: 4

I10-index: 1